Pharmacokinetic variability between and within patients using cenobamate in clinical practice

被引：0
|
作者：
Gottas, A. [1 ]
Kjeldsen, S. F. [1 ]
Listhaug, C. [1 ]
Awad, L. [2 ]
Burns, M. L. [1 ]
Johannessen, S. I. [1 ,3 ]
Landmark, C. Johannessen [1 ,2 ,3 ]
机构：
[1] Oslo Univ Hosp, Sect Clin Pharmacol, Dept Pharmacol, Sandvika, Norway
[2] Oslo Metropolitan Univ, Dept Pharm, Fac Hlth Sci, Oslo, Norway
[3] Oslo Univ Hosp, Natl Ctr Epilepsy, Member ERN EpiCare, Sandvika, Norway
来源：
EPILEPSIA | 2024年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1288
引用
收藏
页码：458 / 458
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetic interaction between cenobamate and clobazam in clinical practice
    Burns, M. L.
    Awad, L.
    Svendsen, T.
    Johannessen, S. I.
    Landmark, C. Johannessen
    EPILEPSIA, 2024, 65 : 156 - 157
  • [2] Pharmacokinetic variability of cannabidiol in clinical practice
    Saetre, J.
    Wolden, M.
    Gottas, A.
    McQuade, T. Angell-Petersen
    Kjeldsen, S. Flood
    Vatevik, A.
    Saetre, E.
    Svendsen, T.
    Burns, M. L.
    Johannessen, S. I.
    Oiestad, E. L.
    Landmark, C. Johannessen
    EPILEPSIA, 2023, 64 : 314 - 315
  • [3] Pharmacokinetic variability of eslicarbazepine in real clinical practice
    de Toledo, Maria
    Valladares-Salado, Laura
    Cebrian-Escudero, Jose
    Diaz-Perez, Carolina
    de la Fuente, Elisa
    Ferreiros, Raquel
    Sanz-Sanz, Elena
    Vega-Piris, Lorena
    Lagares, Alfonso
    Ovejero-Benito, Maria C.
    Sobrado, Monica
    EPILEPSY & BEHAVIOR, 2021, 124
  • [4] 5-FU Monitoring in clinical practice: Pharmacokinetic variability
    Biffi, M.
    Petrelli, F.
    Borgonovo, K.
    Cabiddu, M.
    Ghilardi, M.
    Coinu, A.
    Cremonesi, M.
    Cavalleri, E.
    Pesenti, A.
    Barni, S.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S173 - S174
  • [5] Doxorubicin in Lymphoma: Association Between Pharmacokinetic Variability and Clinical Response
    Elis, Avishay
    Lishner, Michael
    Walker, Scott
    Atias, Dina
    Korenberg, Avraham
    Koren, Gideon
    THERAPEUTIC DRUG MONITORING, 2010, 32 (01) : 50 - 52
  • [6] Between and within Practice Variability Among Practices within the Health Improvement Network
    Haynes, Kevin
    Bilker, Warren B.
    TenHave, Tom R.
    Lewis, James D.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S77 - S78
  • [7] Population Pharmacokinetic Method to Predict Within-Subject Variability Using Single-Period Clinical Data
    Kang, Won-ho
    Lee, Jae-yeon
    Chae, Jung-woo
    Lee, Kyeong-Ryoon
    Baek, In-hwan
    Kim, Min-Soo
    Back, Hyun-moon
    Jung, Sangkeun
    Shaffer, Craig
    Savic, Rada
    Yun, Hwi-yeol
    PHARMACEUTICALS, 2021, 14 (02) : 1 - 11
  • [8] The extent of the pharmacokinetic interaction between clobazam and cannabidiol in clinical practice
    Landmark, C. Johannessen
    Saetre, J.
    Burns, M. L.
    Gottas, A.
    Vatevik, A.
    Saetre, E.
    Svendsen, T.
    Johannessen, S. I.
    EPILEPSIA, 2024, 65 : 168 - 168
  • [9] A retrospective non-interventional study evaluating the pharmacokinetic interactions between cenobamate and clobazam
    Elakkary, Sally
    Hagemann, Anne
    Klimpel, Dennis
    Bien, Christian G.
    Brandt, Christian
    EPILEPSIA, 2023, 64 (04) : e36 - e42
  • [10] Pharmacokinetic variability of anticoagulants in patients with cancer associated thrombosis: Clinical consequences
    Bellesoeur, Audrey
    Thomas-Schoemann, Audrey
    Allard, Marie
    Smadja, David
    Vidal, Michel
    Alexandre, Jerome
    Goldwasser, Francois
    Blanchet, Benoit
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 129 : 102 - 112
12345